PLRX
Pliant Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.16
+2.65%Leverage
- Debt / equity
- 0.20x
- Net debt / equity
- 0.03x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -0.33x
- Net debt / EBITDA
- -0.04x
Liquidity & coverage
- Current ratio
- 9.90x
- Quick ratio
- 9.90x
- Cash ratio
- 9.59x
- Interest coverage
- -102.50x
- EBITDA / interest
- -92.64x
- Working capital
- $146.7M
Cash & dividend
- FCF / debt
- -2.47x
- Cash flow / debt
- -2.47x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026